Gideon Petrover

OncoHost Ltd. is an Israeli technology company that combines life-science research and advanced machine learning technology to develop personalized strategies to maximize the success of cancer therapy. The company utilizes proprietary proteomic analysis to understand a patient's unique response to therapy and overcome resistance to therapy. OncoHost's host response profiling platform (Prophet®) analyzes proteomic changes in blood samples to monitor the dynamics of biological processes induced by the patient in response to a given cancer therapy. OncoHost was founded in 2017, and the CEO is Ofer Sharon.

Nicast Ltd. develops implantable medical devices from electrospun polymer nanofabrics for clinical applications. Its products include AVflo, a vascular access graft that provides for hemodialysis patients; and NovaMesh, a ventral hernia mesh, which offers resistance to tissue adhesion on the visceral-facing surface and promotes tissue ingrowth on the fascial surface. The company was founded by Alex Dubson in 1995 and is headquartered in Lod, Israel.

Nanomedic Technologies Ltd. is an Israeli company that provides a total therapy solution with EHF technology for wound healing and skin regeneration. The private company is based in Lod, Israel and was founded in 2018. The company offers a cutting-edge electrospinning wound care technology in a portable, easy-to-use system that allows for personalized, completely tailored treatment to patient conditions. The Spincare system eliminates the need for painful redressing and allows for transparent, easy monitoring of healing progress. Mark A. Darty has been the CEO of the company since 2021.